Novavax Announces COVID-19 Vaccine Clinical Development Progress

Go back to Novavax Announces COVID-19 Vaccine Clinical Development Progress
Novavax, Inc. (NASDAQ: NVAX) Delayed: 10.98 -1.58 (12.58%)
Previous Close $12.56    52 Week High $9.23 
Open $12.35    52 Week Low $1.16 
Day High $13.33    P/E N/A 
Day Low $10.92    EPS $-0.30 
Volume 14,498,560       

Novavax, Inc. (NASDAQ: NVAX) Delayed: 10.98 -1.58 (12.58%)
Previous Close $12.56    52 Week High $9.23 
Open $12.35    52 Week Low $1.16 
Day High $13.33    P/E N/A 
Day Low $10.92    EPS $-0.30 
Volume 14,498,560